Cargando…
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases
Prion diseases are fatal neurodegenerative conditions with highly accurate CSF and imaging diagnostic tests, but major unmet needs for blood biomarkers. Using ultrasensitive immuno-assays, we measured tau and neurofilament light chain (NfL) protein concentrations in 709 plasma samples taken from 377...
Autores principales: | Thompson, Andrew G. B., Anastasiadis, Prodromos, Druyeh, Ronald, Whitworth, Ines, Nayak, Annapurna, Nihat, Akin, Mok, Tze How, Rudge, Peter, Wadsworth, Jonathan D. F., Rohrer, Jonathan, Schott, Jonathan M., Heslegrave, Amanda, Zetterberg, Henrik, Collinge, John, Jackson, Graham S., Mead, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758487/ https://www.ncbi.nlm.nih.gov/pubmed/33674752 http://dx.doi.org/10.1038/s41380-021-01045-w |
Ejemplares similares
-
Enteral feeding is associated with longer survival in the advanced stages of prion disease
por: McNiven, Kirsty, et al.
Publicado: (2019) -
Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases
por: Mok, Tze How, et al.
Publicado: (2021) -
Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases
por: Reiniger, Lilla, et al.
Publicado: (2013) -
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study
por: Sequeira, Danielle, et al.
Publicado: (2022) -
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
por: Weston, Philip S. J., et al.
Publicado: (2019)